Lenakast 10 mg contains Lenalidomide, a potent immunomodulatory agent (IMiD) widely prescribed in hematologic malignancies. It is often used as maintenance therapy or in combination with other anticancer agents to improve long-term disease control.

🔬 Mechanism of Action

Lenalidomide works through multiple mechanisms:

• Stimulates T-cells and natural killer (NK) cells
• Inhibits tumor cell proliferation
• Suppresses angiogenesis (blood vessel formation)
• Promotes apoptosis of malignant cells

This multi-pathway activity makes it highly effective in blood cancers.

💊 Indications

Lenakast 10 mg is indicated for:

• Multiple Myeloma (MM) (including maintenance therapy after stem cell transplant)
• Myelodysplastic Syndromes (MDS) with deletion 5q abnormality
• Mantle Cell Lymphoma (MCL) after prior therapy
• Follicular Lymphoma (FL) as part of combination treatment

📌 Key Features

• Strength: 10 mg

• Dosage Form: Oral capsule
• Therapeutic Class: Immunomodulatory Agent (IMiD)
• Administration: Typically taken once daily for 21 days followed by 7 days off (28-day cycle), or as prescribed
• Monitoring: Regular complete blood count (CBC), kidney function tests, and pregnancy prevention monitoring required

⚕️ Benefits

• Enhances immune-mediated cancer control
• Effective as maintenance therapy in multiple myeloma
• Improves progression-free survival
• Convenient oral administration

⚠️ Precautions

• Risk of neutropenia and thrombocytopenia
• Increased risk of blood clots
• Strict pregnancy prevention program required (teratogenic risk)
• Dose adjustments required in renal impairment
• Use strictly under hematologist/oncologist supervision

Lenakast 10 mg (Lenalidomide Capsules) is a key immunomodulatory therapy in modern hematology, supporting effective long-term management of multiple myeloma and related blood disorders when used under expert medical care.